Medical treatment in head and neck squamous cell carcinoma / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 94-97, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-743096
ABSTRACT
Medical treatment is an important strategy for patients with head and neck squamous cell carcinoma (HNSCC).Studies have shown that three-weekly cisplatin regimen is a promising treatment for patients with locally advanced HNSCC and cetuximab plus platinum and 5-fluorouracil can be the first-line therapy for patients with recurrent or metastatic HNSCC.Current results from immunotherapy trials have shown an improved response rate and overall survival in patients with recurrent or metastatic HNSCC while maintaining a safe and tolerable toxicity profile.Immunotherapy is becoming the fourth treatment strategy towards cancer.There is still insufficient evidence that patients with HNSCC can benefit from induction chemotherapy and further study is warranted.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of International Oncology
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS